Author:
Liu Bin,Liu Yan,Liu Wenju,Lin Cuibo,Lin Lin,Chen Weiting,Lin Wanzhen,Chen Wei,Lin Jie
Funder
Natural Science Foundation of Fujian Province
Fujian Provincial Health Technology Project
Startup Fund for Scientific Research, Fujian Medical University, China
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12–49.
2. Nogueira-Costa G, Eiriz I, Braga S. Non-endometrioid endometrial cancer: analysis of different adjuvant treatment modalities. Cancer Treat Res Commun. 2022;32:100581.
3. Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso G, et al. Endometrial carcinosarcoma. Int J Gynecol Cancer. 2023;33:147–74.
4. Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol. 2004;95:593–6.
5. Goto T, Takano M, Aoyama T, Miyamoto M, Watanabe A, Kato M, et al. Prognosis of high-grade endometrial cancer: a comparison of serous-type and clear cell type to grade 3 endometrioid-type. Eur J Gynaecol Oncol. 2012;33:579–83.